(4-Bromo-3-(trifluoromethyl)phenyl)boronic acid, 95.0%, 1g

(S)-N-1-Boc-N-4-Cbz-2-Piperazine carboxylic acid, 98.0%, 100mg

1,2-Dibromo-4-chloro-5-methylbenzene, 98%, 25g

(R)-4-((5S,7R,8R,9S,10S,12S,13R,14S,17R)-7,12-dihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid, 50mg

Volumetric pipettes 1 marking, class AS, 2 ml, 12 pieces

2-(hydroxymethyl)-1,4-dihydropyridin-4-one, 97%, 1g

Tert-butyln-(4-formyl-1-bicyclo[2.2.2]octanyl)carbamate, 98%, 500mg

Methyl 3-bromo-1-methyl-1H-indole-6-carboxylate, 95.0%, 5g

1-(2-Chloropyridin-4-yl)piperazine, 95.0%, 100mg

Methyl 5-Bromo-2-iodobenzoate>95.0%(GC)5g

1,1,3,3,5,5 -Hexamethylcyclotrisilazane, 97.0%(GC)(T), 25g

Hydroxy{[(4-methylphenyl)sulfonyl]oxy}phenyliodine (HTIB), 98.00%, 500g

2-(Morpholin-3-yl)ethan-1-ol hydrochloride, 97%, 25mg